Brian Schwartz
0000-0003-2632-6351
1 paper found
Refreshing results…
First in Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma
Missing publications? Search for publications with a matching author name.